Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Ann-Marie Roche

Director, Corporate Markets Marketing, Elsevier

Connect with Ann-Marie Roche on LinkedIn
Website:

About the author: An experienced and passionate global marketing leader in creating useful, usable and enjoyable customer experiences. I started my career as a researcher and after joining Elsevier, I have had the opportunity to get closer to the fascinating world of Life Sciences, which I now use to identify and further explore key issues such as data as a service, AI, data extraction and personalized medicine. My goal is to engage with my audience and support knowledge sharing and discussion.

Posts by Ann-Marie Roche

Pharma’s path to Net Zero

Posted on May 3rd, 2022 in Pharma R&D

Pharma is seldom top of mind when thinking about the most polluting industries, but pharmaceutical industry operations are in fact responsible for a significant portion of the world’s greenhouse gas emissions – even rivaling industries that are far more associated with contributing to the problem. 

(more…)

Elsevier and LG: Turning data into action

Posted on April 28th, 2022 in AI & Data

There are life-changing insights waiting to be found in chemistry data. The critical information waiting to be unlocked can lead to incredible technology advances and medical breakthroughs. But there is so much data out there, and it is multiplying rapidly. At Elsevier, we are excited about a new partnership with world-renowned innovator LG that we are confident will enable researchers to discover and surface more relevant chemistry facts and relationships from scientific literature than ever before.

(more…)

Pharma can now track the most relevant patent info – fast and at scale

Posted on April 26th, 2022 in AI & Data

Since its initial release in January 2021, AI-fueled Patent Expansion in Reaxys has won the respect of pharmaceutical companies trying to stay ahead of their competitors by keeping track of the latest patents around drug discovery and new therapeutics. With a recent expansion that allows Reaxys to also loop in information from images found in patents, it’s a good time to look back – and forward – at this continual work-in-progress. We spoke to Umesh Nandal, Elsevier’s Director of Data Science, about the logic behind the tech: “It’s not just about the speed of access to all this annotated data, but the quality.”

(more…)

Elsevier research partner Karin Verspoor nominated for Women in AI award

Posted on April 5th, 2022 in AI & Data

Network

In recognition of her numerous research accomplishments, Professor Karin Verspoor is nominated for the prestigious Women in AI Award under the ‘AI in Innovation’ category. Certainly, the interdisciplinary work she has undertaken with Elsevier has chemists and pharmaceutical companies excited about the real-world impact of automating the extraction of chemical reaction information from patents.

(more…)

  1. 1
  2. 2
  3. 3
  4. 9